Rationale of Technical Requirements for NRG-BR001: The First NCI-Sponsored Trial of SBRT for the Treatment of Multiple Metastases

INTRODUCTION: In 2014, the NRG Oncology Group initiated the first NCI-sponsored, phase I clinical trial of SBRT for the treatment of multiple metastases in multiple organ sites (XXXX; NCTXXX). The primary endpoint is to test the safety of SBRT for the treatment of multiple lesions (2–4) in several a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pract Radiat Oncol
Autors principals: Al-Hallaq, Hania A, Chmura, Steven, Salama, Joseph K, Winter, Kathryn A, Robinson, Clifford G, Pisansky, Thomas M, Borges, Virginia, Lowenstein, Jessica L, McNulty, Susan, Galvin, James M, Followill, David S, Timmerman, Robert D, White, Julia R, Xiao, Ying, Matuszak, Martha M
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099083/
https://ncbi.nlm.nih.gov/pubmed/27345129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2016.05.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars